SCHEMBL4364883

SCHEMBL4364883

CC(C)c1ccc(/C=C2\SC(N3CCN(c4ccccc4F)CC3)=NC2=O)cc1

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.71
ALDH1A1 P00352 3/20 0.55
DCTPP1 Q9H773 1/20 0.53
MAPT P10636 3/20 0.53
NPC1 O15118 4/20 0.53
RAB9A P51151 3/20 0.53
ENPP2 Q13822 2/20 0.53
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
GRIN1 Q05586 3/20 0.52
GRIN2B Q13224 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.51
LMNA P02545 1/20 0.51
HPGD P15428 1/20 0.51
MAPK1 P28482 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
ALOX5 P09917 1/20 0.49
IDE P14735 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4364886 1.00 HTT (0.71) HTTALDH1A1DCTPP1MAPTNPC1
SCHEMBL4350031 0.88 MAPT (0.69) HTTALDH1A1DCTPP1MAPTNPC1
SCHEMBL4350035 0.88 MAPT (0.69) HTTALDH1A1DCTPP1MAPTNPC1
SCHEMBL4352214 0.85 ALDH1A1 (0.71) HTTALDH1A1DCTPP1MAPTNPC1
SCHEMBL4352217 0.85 ALDH1A1 (0.71) HTTALDH1A1DCTPP1MAPTNPC1
SCHEMBL4352779 0.84 MAPT (0.56) HTTALDH1A1DCTPP1MAPTNPC1
SCHEMBL4352782 0.84 MAPT (0.56) HTTALDH1A1DCTPP1MAPTNPC1
SCHEMBL4350565 0.82 ALDH1A1 (0.53) ALDH1A1DCTPP1MAPTNPC1RAB9A
SCHEMBL4350559 0.82 ALDH1A1 (0.53) ALDH1A1DCTPP1MAPTNPC1RAB9A
SCHEMBL4359625 0.81 HTT (0.82) HTTALDH1A1DCTPP1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 HTT 645/4885ALDH1A1 284/4885DCTPP1 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.